Nuzenio

Replimune Group Inc

Replimune Group Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 17 publisher sources 100/100 entity strength

Latest news

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Replimune Group Inc. (REPL) and Encourages Investors to Learn More About the Investigation - ACCESS NewswireACCESS Newswire · Sun, 09 Aug 2026 18:56:02 GMTReplimune in the spotlight: Earnings loom days after FDA approval - Investing.comInvesting.com · Sun, 09 Aug 2026 13:35:00 GMTWhy Is REPL Stock Soaring 127% After Hours Today? - StocktwitsStocktwits · Sat, 08 Aug 2026 04:42:54 GMTREPL Vs IOVA: FDA Decision Day Could Test Biotech Bulls’ Conviction On These Melanoma Plays - StocktwitsStocktwits · Sat, 08 Aug 2026 03:13:33 GMTReplimune Group Price Target Raised to $20.00/Share From $17.00 by JP Morgan - MoomooMoomoo · Sat, 08 Aug 2026 01:48:35 GMTReplimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line - TradingViewTradingView · Sat, 08 Aug 2026 00:31:44 GMTREPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law - Business WireBusiness Wire · Fri, 07 Aug 2026 21:07:00 GMTReplimune Group Investors Reminder for Upcoming Lawsuit Deadline - Intellectia AIIntellectia AI · Fri, 07 Aug 2026 19:56:24 GMT

Timeline

Sun, 09 Aug 2026 18:56:02 GMTBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Replimune Group Inc. (REPL) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Sun, 09 Aug 2026 13:35:00 GMTReplimune in the spotlight: Earnings loom days after FDA approval - Investing.com
Sat, 08 Aug 2026 04:42:54 GMTWhy Is REPL Stock Soaring 127% After Hours Today? - Stocktwits
Sat, 08 Aug 2026 03:13:33 GMTREPL Vs IOVA: FDA Decision Day Could Test Biotech Bulls’ Conviction On These Melanoma Plays - Stocktwits
Sat, 08 Aug 2026 01:48:35 GMTReplimune Group Price Target Raised to $20.00/Share From $17.00 by JP Morgan - Moomoo
Sat, 08 Aug 2026 00:31:44 GMTReplimune’s First Commercial Drug Arrives—With A 2027 Cash Cliff And 2030 Finish Line - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Replimune Group Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

17 distinct publisher/source names are currently connected to this entity page.